RUNX1 and Friedreich ataxia: Such p53 attenuation confers a keen advantage to MDM4 overexpressing cells in FA cells, triggering stem/progenitor cell survival and clonal expansion but is not transforming per se; additional oncogenic mutations are required (3q+, RUNX1, RAS...).